You are an expert biomedical scientific-writing reviewer performing a rigorous peer-review-style evaluation.

Your job: score the candidate model's generated "Methods" section against the source evidence for a methods_to_text task, using the rubric below. Be strict and specific. Punish invented numbers, invented experiments, misattributed figures, and claims that cannot be traced to the provided evidence. Reward outputs whose details are demonstrably present in the evidence.

## Rubric axes (score each 0.0 to 1.0)

- `writing_structure_compliance`
- `evidence_grounding`
- `factual_fidelity`
- `traceability`
- `hallucination_absence`

Axis definitions:

- writing_structure_compliance: Does the output open with the expected section heading and follow a plausible section structure (appropriate level of detail, logical flow, typical subsections for the task family)?
- evidence_grounding: Is every non-trivial claim traceable to specific content in the source evidence? Penalize free-floating claims.
- factual_fidelity: Do quantitative values, qualifiers ("significantly", "modestly"), organisms, time points, sample sizes, and cited figures/tables exactly match the source? Any mismatch is a serious deduction.
- traceability: Are evidence identifiers, section pointers (e.g. "methods_section", "abstract_section"), figure/table references, or accessions cited where useful? 0.0 if there are zero references; 1.0 if they are pervasive and correct.
- hallucination_absence: Is the output free of fabricated content (made-up citations, phantom experiments, invented numerical values)? 1.0 = no hallucinations found; 0.0 = at least one clear fabrication.

## Pass threshold

An axis is considered passing at >= 0.6. overall_pass is true if and only if every axis is at or above that threshold.

## Source evidence

## Abstract
Background:Heyndrickxia coagulans has emerged as a candidate for oral health applications, and chewing gum offers a promising delivery method. This study evaluates whether H. coagulans delivered via sugar-free chewing gum can induce detectable changes in plaque microbial ecology. Methods: A randomized, double-blind, placebo-controlled clinical trial was conducted on 52 healthy adults. Participants consumed probiotic or control gum for 4 weeks. Dental plaque was collected at baseline (T0), mid-intervention (T1), end of intervention (T2), and one week post-intervention (T3). qPCR quantified H. coagulans, while 16S rRNA gene profiling assessed microbial diversity and taxonomic composition. Statistical analyses included rank-based difference-in-differences models, Wilcoxon and Mann-Whitney tests, and differential abundance inference based on negative binomial modeling. Results: Forty-four subjects completed the study. In the Intervention group, the strain was detected in 71.4% of participants at T1 and 61.9% at T2, and it persisted in 9.5% at T3. Differential abundance analysis revealed a broad depletion of taxa linked to oral dysbiosis at T2 with partial persistence at T3, along with selective enrichment of beneficial strains. Conclusions:H. coagulans delivered via chewing gum can reach the dental biofilm and induce modest, transient shifts in microbial composition. However, these biofilm ecology findings should be interpreted in the context of clinical outcomes.

## Results
2.5. Outcomes Assessment Follow-up assessments were conducted at the following time points: after the initial two-week washout period (T 0 ), after two weeks of chewing gum use (T 1 ), after four weeks of chewing gum use (T 2 ), and after an additional week at the end of the post-intervention period (T 3 ) ( Figure 1 ). Figure 1 Chewing gum administration schedule and sample collection timeline. The primary outcome assessed was the characterization of the dental plaque microbial ecosystem. The secondary outcome was qPCR-based detection of H. coagulans SNZ1969 ® in dental plaque in subjects who received the probiotic-containing chewing gum. 3. Results 3.1. Sample Characteristics A total of 52 volunteers (26 per group) started the 2-week washout period. Three participants in the Intervention group were excluded: one for non-compliance with the washout instructions, and two owing to health complications that emerged after enrolment. Subsequently, chewing gum administration was initiated by 23 participants in the Intervention group and 26 in the Control group. During the study, one participant in the Control group dropped out due to dislike of the gum’s taste, while another participant in the Intervention group withdrew because of gastrointestinal disorders; therefore, they were excluded from the first follow-up (T 1 ). Before the second follow-up (T 2 ), two additional participants in the Control group were excluded: one discontinued chewing gum due to gastrointestinal disorders, and another missed the follow-up for personal reasons. Ultimately, 21 participants in the Intervention group and 23 in the Control group completed the study (drop out 13.5%). Figure 2 and Supplementary File S4 show recruitment, randomization, and follow-up of participants in the clinical trial. Figure 2 Flow diagram of participant recruitment, randomization, and follow-up in the clinical trial. The mean age of participants was 27.9 years (29.3 ± 10.5 in the Intervention group and 27.0 ± 8.2 in the Control group), and 85.7% were female (20 in the Intervention group and 22 in the Control group) ( Table 1 ). Table 1 Characteristics of participants, compliance and adverse effects reported in the two study groups during the experimental period. Intervention Control Total p Value N = 23 N = 26 N = 49 Age (years) Mean (SD) 29.3 (10.5) 27.0 (8.2) 27.9 (9.0) 0.665 c Range 20.0; 55.0 20.0; 53.0 20.0; 55.0 Sex ( n (%)) F 20 (87.0) 22 (84.6) 42 (85.7) 1.000 a M 3 (13.0) 4 (15.4) 7 (14.3) Compliance N (%) of subjects that skipped chewing gum during Intervention period 7 (30.4) 4 (15.4) 11 (22.5) 0.306 a Chewing gum skipped Mean (SD) 1.3 (2.8) 0.8 (2.1) 1.0 (2.4) 0.285 c Range 0.0; 12.0 0.0; 8.0 0.0–12.0 Dislike ( n (%) of subjects that disliked chewing gum) 5 (21.7) 4 (15.4) 9 (18.4) 0.716 a Adverse effect ( n (%) of subjects that referred to gastrointestinal disorders) 10 (43.5) 7 (26.9) 17 (34.7) 0.224 b N : number; SD: standard deviation; M: male; F: female. Normality and heteroskedasticity of continuous data were assessed with Shapiro–Wilk test. a —Fisher’s exact test; b —Chi-square test; c —Mann–Whitney U test. A total of 11 participants (7 in the Intervention group and 4 in the Control group) did not fully adhere to the chewing gum regimen; the mean of missed gums was 1.0 ± 2.4/140 (range 0–12). Nine participants (5 in the Intervention group and 4 in the Control group) reported disliking the taste, texture, or size of the chewing gum. Furthermore, 17 participants (10 in the Intervention group and 7 in the Control group) reported gastrointestinal side effects, including bloating, reflux, gastritis, and abdominal pain. No statistically significant differences were found between groups ( Table 1 ). Final analyses were conducted on the 44 subjects who completed the study (mean age: 29.5 in the Intervention group and 27.4 in the Control group). No statistically significant differences were observed in age or sex between participants who used the probiotic chewing gum and those who used the control chewing gum. 3.2. Presence of H. coagulans in Dental Plaque Samples A total of 107 dental plaque samples (T 0 n = 44; T 1 n = 21; T 2 n = 21; T 3 n = 21) were analyzed by qPCR for the detection of strain H. coagulans SNZ1969. Values are expressed as Log 10 cell equivalents per ng of DNA (Log 10 cells/ng). The limit of detection (LOD) was 1.3 Log 10 cells/ng; values below the LOD are reported as under the detection limit ( u.d.l .). In the Control group ( n = 2...

## Figure captions
1. Figure 1. Chewing gum administration schedule and sample collection timeline.
2. Figure 2. Flow diagram of participant recruitment, randomization, and follow-up in the clinical trial.
3. Figure 3. qPCR-based detection levels of probiotic strain H. coagulans at different follow-up points of subjects in Intervention group. u.d.l ., under detection limit (<1.3 Log 10 cells/ng).
4. Figure 4. Alpha-diversity metrics of dental plaque microbiota across study groups and time points. Boxplots represent the distribution of ( A ) Faith’s phylogenetic diversity, ( B ) observed features (richness), ( C ) Pielou’s evenness, and ( D ) Shannon entropy in the Control and Intervention groups at baseline (T 0 ), end of intervention (T 2 ), and follow-up (T 3 ). Each dot corresponds to an individual sample. Significant differences in deltas between groups were observed during the Intervention phase (T 0 –T 2 ) for Faith’s phylogenetic diversity ( p = 0.0027) and Pielou’s evenness ( p...
5. Figure 5. Principal coordinate analysis (PCoA) plots based on weighted UniFrac (wUniFrac), unweighted UniFrac (uwUniFrac), Jaccard, and Bray–Curtis dissimilarities. The first two coordinates (PC1 and PC2) are shown, with the proportion of variance explained indicated on each axis. Samples are colored by time point (red = T 0 , blue = T 2 , green = T 3 ) and stratified by treatment group (Control and Intervention). Arrows connect longitudinal samples from the same subject (T 0 → T 2 → T 3 ), illustrating temporal trajectories. No clear clustering by time point was observed across either trea...

## Table snippets
1. Table 1. Characteristics of participants, compliance and adverse effects reported in the two study groups during the experimental period. | Intervention; Control; Total; p Value; N = 23; N = 26
2. Table 2. qPCR-based detection of probiotic strain of H. coagulans in oral samples from subjects in Intervention group. Values are reported as Log 10 of target-gene copies (cell equivalents) per ng of extracted DNA (Log 10 cells/ng). | ID; T 0; T 1; T 2; T 3; 3
3. Table 3. Statistical analysis of alpha-diversity metrics in dental plaque across study groups and timepoints. Pairwise comparisons were performed using Mann–Whitney U tests (MWU) on deltas (between-group, Control vs. Intervention) and Wilcoxon signed-rank tests (within-group, paired across timepoints). The number of subjects per group ( n ), raw p -values, and false discovery rate (FDR)-adjusted q-values are reported (Benjamini–Hochberg correction applied across all tests). Significant results at p < 0.05 are highlighted in bold in the text, although none survived FDR correction (q < 0.05)....
4. Table 4. Pairwise comparisons of beta-diversity principal coordinates among time points (T 0 , T 2 , T 3 ) in the Control and Intervention groups. p -values were obtained using the non-parametric Mann–Whitney U test applied to the first two principal coordinates (PC1, PC2) derived from weighted UniFrac (wUniFrac), unweighted UniFrac (uwUniFrac), Jaccard, and Bray–Curtis dissimilarities. No comparison reached statistical significance ( p < 0.05), although borderline values were observed for uwUniFrac (Control, T 0 vs. T 3 , PC1) and for Bray–Curtis (Intervention, T 0 vs. T 2 , PC2). | Method...
5. Table 5. ANOSIM results for beta-diversity comparisons among time points (T 0 , T 2 , T 3 ) in the Control and Intervention groups. Analyses were conducted on Euclidean distance matrices calculated from the first two principal coordinates (PC1 and PC2) derived from weighted UniFrac (wUniFrac), unweighted UniFrac (uwUniFrac), Jaccard, and Bray–Curtis dissimilarities. The table reports R statistics and permutation-based p -values (999 permutations) for global (T 0 vs. T 2 vs. T 3 ) and pairwise comparisons. All R values were close to zero or negative, indicating no meaningful separation betwe...
6. Table 6. Differentially abundant bacterial taxa between the Intervention and Control groups. (A) Taxa significantly modulated at T 2 (end of probiotic treatment). (B) Taxa significantly modulated at T 3 (post-treatment follow-up). Results derive from a DESeq2-like model testing the time × treatment interaction. Coefficients (Coef_log_rate) indicate the relative change in abundance in the Intervention group compared to the Control group at each timepoint; positive values indicate a greater increase (or smaller decrease), negative values indicate the opposite. The table reports taxonomic clas...
7. CFU; Colony-Forming Units; MRD; Maximum Recovery Diluent; ppm; Parts Per Million

## Candidate output (to be judged)

Methods

This study was conducted as a randomized, double-blind, placebo-controlled clinical trial. The protocol was designed to evaluate whether *Heyndrickxia coagulans* SNZ1969® delivered via sugar-free chewing gum could induce detectable changes in dental plaque microbial ecology, as detailed in the **methods_section** and summarized in the **abstract_section**. A total of 52 healthy adult volunteers were recruited and, following a two-week washout period, randomly allocated to either a probiotic or a control gum group. Participants chewed their assigned gum for four weeks. Dental plaque samples were collected at four time points: baseline (T0), after two weeks of intervention (T1), at the end of the four-week intervention (T2), and after a one-week post-intervention period (T3); the schedule is illustrated in the **section_text** referring to Figure 1. The primary outcome was the characterization of the plaque microbial ecosystem via 16S rRNA gene profiling to assess diversity and taxonomic composition. The secondary outcome was the quantitative detection of the probiotic strain in plaque using qPCR. Microbial DNA was extracted from all collected plaque samples. Statistical analysis of the microbial **evidence** included rank-based difference-in-differences modeling to compare changes between groups over time, with Wilcoxon signed-rank and Mann-Whitney U tests for within- and between-group comparisons of alpha-diversity metrics, respectively. Beta-diversity was assessed using multiple distance metrics. Differential abundance of bacterial taxa was inferred using a negative binomial modeling approach. All analyses were performed on the per-protocol population of participants who completed the study, with results for this cohort presented in the **results_section**. Participant flow, compliance, and adverse events were documented throughout.

## Output format

Respond with ONLY a single JSON object. No prose before or after. No markdown code fences. The JSON must match this schema exactly:

{
  "axis_scores": {
    "writing_structure_compliance": <float 0.0-1.0>,
    "evidence_grounding": <float 0.0-1.0>,
    "factual_fidelity": <float 0.0-1.0>,
    "traceability": <float 0.0-1.0>,
    "hallucination_absence": <float 0.0-1.0>
  },
  "axis_rationales": {
    "writing_structure_compliance": "<1-3 sentences>",
    "evidence_grounding": "<1-3 sentences>",
    "factual_fidelity": "<1-3 sentences>",
    "traceability": "<1-3 sentences>",
    "hallucination_absence": "<1-3 sentences>"
  },
  "grounding_issues": [
    "<specific concern citing the exact claim and why it is unsupported or inconsistent with the evidence>"
  ],
  "overall_pass": <true or false>
}